By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Windtree Therapeutics, Inc. (Formerly Known As Discovery Laboratories, Inc.) 

2600 Kelly Road

Warrington  Pennsylvania  18976  U.S.A.
Phone: 215-488-9300 Fax: 215-488-9301



Company News
Windtree Therapeutics (WINT) Receives SBIR Grant In Continued Support Of AEROSURF Phase IIb Clinical Trial 5/23/2017 6:50:59 AM
Windtree Therapeutics (WINT) Reports First Quarter 2017 Financial Results And Provides Key Business Updates 5/16/2017 10:40:09 AM
Windtree Therapeutics (WINT) Receives Notice Of Delisting From NASDAQ 5/4/2017 7:29:24 AM
Windtree Therapeutics (WINT) Announces Successful Completion Of Second And Final AEROSURF Phase IIb Clinical Trial Interim Safety Review 4/11/2017 7:36:09 AM
Windtree Therapeutics (WINT) Reports Fourth Quarter 2016 Financial Results And Provides Key Business Updates 3/31/2017 9:14:03 AM
Windtree Therapeutics (WINT) Completes $10.5 Million Private Offering 2/16/2017 7:34:03 AM
Windtree Therapeutics (WINT)' Aerosolized KL4 Surfactant Reduces Lung Inflammation And Improves Survival In A High-Pathogen Avian Influenza Preclinical Study 2/16/2017 7:19:09 AM
Windtree Therapeutics (WINT)' AEROSURF (Lucinactant For Inhalation) Phase 2a Data Presented At The 2016 International Congress Of Union Of European Neonatal And Perinatal Societies 11/29/2016 6:31:24 AM
Windtree Therapeutics (WINT) Preclinical Study Results Show Potential For KL4 Surfactant As Possible Medical Countermeasure To Radiation Exposure 11/4/2016 8:52:28 AM
Windtree Therapeutics (WINT) Releases Data From Lung Deposition Study In Non-Human Primates Demonstrating Uniform Distribution Of Aerosolized KL4 Surfactant In All Regions Of The Lung 10/25/2016 6:51:48 AM